Ipamorelin

Overview

Ipamorelin is a selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin.

Mechanism
May support:
Candidate Considerations
Safety

Compounded ipamorelin is prescribed only after medical evaluation and is not FDA-approved for disease treatment.

Consultation

$300 Total Peptide Program
Includes your medical consultation and one peptide medication, if prescribed.

Frequently Asked Questions

Ipamorelin is not FDA-approved for disease treatment and is available only through compounded prescriptions.

It may be legally prescribed by a licensed physician when clinically appropriate.

Ipamorelin is typically administered via subcutaneous injection, often in the evening.

Patients with certain endocrine disorders or medical conditions should be evaluated before use.